INTRODUCTION: Cardiac magnetic resonance (CMR)-identified late gadolinium enhancement (LGE), representing regional fibrosis, is often used to predict ventricular arrhythmia risk in nonischemic cardiomyopathy (NICM). However, LGE is more closely correlated with sustained monomorphic ventricular tachycardia (SMVT) than ventricular fibrillation (VF). We characterized CMR findings of ventricular LGE in VF survivors. METHODS: We examined consecutively resuscitated VF survivors undergoing contrast-enhanced 1.5T CMR between 9/2007 and 7/2016. We excluded coronary artery disease, hypertrophic cardiomyopathy, amyloid, sarcoid, arrhythmogenic right ventricular cardiomyopathy, and channelopathy. Preexisting implantable cardioverter-defibrillator (ICD)...
Objectives: We investigated the prognostic role of myocardial fibrosis by delayed enhancement (DE) c...
OBJECTIVE: Myocardial fibrosis identified by late gadolinium enhancement (LGE) cardiovascular magnet...
AbstractObjectivesThe aim of this study was to describe the role of contrast-enhanced cardiac magnet...
ObjectivesWe examined whether the presence and extent of late gadolinium enhancement (LGE) by cardio...
BACKGROUND: Current risk stratification for sudden cardiac death (SCD) in nonischemic dilated cardi...
BACKGROUND: Left ventricular late gadolinium enhancement (LV-LGE) by cardiac magnetic resonance (CMR...
BACKGROUND: Left ventricular late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR) h...
ObjectivesThis study sought to determine whether the extent of late gadolinium enhancement (LGE) can...
Objectives We performed a meta-analysis to evaluate the predictive value of late gadolinium enhance...
Background Aim of the study was to investigate whether late gadolinium enhancement (LGE) at cardiac ...
ObjectivesThe goal of this study was to explore whether fibrosis detected by late gadolinium enhance...
Background: Late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) has been s...
Background: In non-ischaemic dilated cardiomyopathy (NIDCM), it is uncertain which late gadolinium e...
Objectives: We investigated the prognostic role of myocardial fibrosis by delayed enhancement (DE) c...
OBJECTIVE: Myocardial fibrosis identified by late gadolinium enhancement (LGE) cardiovascular magnet...
AbstractObjectivesThe aim of this study was to describe the role of contrast-enhanced cardiac magnet...
ObjectivesWe examined whether the presence and extent of late gadolinium enhancement (LGE) by cardio...
BACKGROUND: Current risk stratification for sudden cardiac death (SCD) in nonischemic dilated cardi...
BACKGROUND: Left ventricular late gadolinium enhancement (LV-LGE) by cardiac magnetic resonance (CMR...
BACKGROUND: Left ventricular late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR) h...
ObjectivesThis study sought to determine whether the extent of late gadolinium enhancement (LGE) can...
Objectives We performed a meta-analysis to evaluate the predictive value of late gadolinium enhance...
Background Aim of the study was to investigate whether late gadolinium enhancement (LGE) at cardiac ...
ObjectivesThe goal of this study was to explore whether fibrosis detected by late gadolinium enhance...
Background: Late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) has been s...
Background: In non-ischaemic dilated cardiomyopathy (NIDCM), it is uncertain which late gadolinium e...
Objectives: We investigated the prognostic role of myocardial fibrosis by delayed enhancement (DE) c...
OBJECTIVE: Myocardial fibrosis identified by late gadolinium enhancement (LGE) cardiovascular magnet...
AbstractObjectivesThe aim of this study was to describe the role of contrast-enhanced cardiac magnet...